Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
CUE similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Cue Biopharma, Inc.
We hereby consent to the use in the Form 10-K for the year ended December 31, 2018 of our report dated March 29, 2018, relating to the balance sheet of Cue Biopharma, Inc. as of December 31, 2017, and the related statements of operations, stockholders’ equity and cash flows for the year ended December 31, 2017, and the related notes, which is included in the Form 10-K for the year ended December 31, 2018.
/s/ Gumbiner Savett Inc.
March 14, 2019
Santa Monica, California